September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents ...
August 30, 2022
Feature | Cardiovascular Business | By Christine Book
As the cardiology community commemorates the importance of heart health on World Heart Day, Sept. 29, here’s a quick ...
August 18, 2022
July 25, 2022 DalCor Pharmaceuticals announced the results of the dal-GenE Phase 3 cardiovascular precision medicine ...
July 25, 2022
May 24, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost ...
May 24, 2022
May 24, 2022 — The U.S. Food and Drug Administration (FDA) has issued a statement that Teva Pharmaceuticals USA has ...
May 24, 2022
May 17, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost ...
May 17, 2022
May 13, 2022 — Bristol Myers Squibb’s mavacamten will stand rather unchallenged in the hypertrophic cardiomyopathy (HCM) ...
May 13, 2022
May 5, 2022 — High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a ...
May 05, 2022
April 29, 2022 — Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Camzyos ...
April 29, 2022
April 12, 2022 – A majority of patients with obstructive hypertrophic cardiomyopathy (HCM)—a condition that results in ...
April 12, 2022
April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...
April 08, 2022
April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...
April 06, 2022
April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...
April 07, 2022
April 4, 2022 – Esperion presented two new analyses from its clinical development program of bempedoic acid (NEXLETOL) ...
April 04, 2022